L26/P-126 Reproductive ageing in the young: Impact of preimplantation genetic testing on cumulative live birth outcomes in POSEIDON Group 3 women
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von R. Nayak und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can preimplantation genetic testing (PGT) improve cumulative live birth rate and reproductive efficiency in young women with low ovarian reserve classified as POSEIDON Group 3? Summary answer In young-women with low-ovarian reserve, PGT was associated with higher implantation, live-birth per transfer and cumulative live birth per retrieval, despite higher cycle cancellation. What is known already POSEIDON Group 3 women are chronologically young but exhibit features of early reproductive ageing due to diminished ovarian reserve. Although embryo aneuploidy rates are generally lower in younger women, reduced oocyte yield limits embryo availability and may compromise cumulative reproductive outcomes. The role of PGT in this subgroup remains controversial, with most evidence focused on per-transfer success rather than cumulative live birth or overall treatment efficiency. Study design, size, duration This observational cohort study was conducted at a tertiary IVF centre between 2018 and 2024. A total of 393 women aged <35 years with AMH <1.2 ng/mL fulfilling POSEIDON Group 3 criteria underwent a single ovarian stimulation cycle with blastocyst culture. Cycles were categorised into a PGT group (n = 162) and a non-PGT group (n = 231), with follow-up until cumulative live birth per oocyte retrieval. Participants/materials, setting, methods In the PGT group, blastocysts underwent trophectoderm biopsy with chromosomal analysis using next-generation sequencing. In the non-PGT group, embryos were selected based on standard morphological criteria (Gardner grading). All embryos were cryopreserved and patients underwent up to three frozen embryo transfers from the same oocyte retrieval. Laboratory, clinical and cumulative outcomes were compared using chi-square or Fisher’s exact tests, with odds ratios and 95% confidence intervals. Main results and the role of chance A total of 393 cycles were analysed (162 PGT; 231 non-PGT). Cycle cancellation due to absence of transferable blastocysts was higher in the PGT group (30% vs 13%, p < 0.001), reflecting intrinsic oocyte and embryo competence variability rather than the testing procedure itself. Laboratory outcomes were otherwise comparable, although PGT cycles demonstrated higher MII oocyte rate (82% vs 74%, p < 0.0001), fertilisation rate (93% vs 89%, p = 0.0019), and blastocyst formation rate (59% vs 46%, p < 0.0001), consistent with underlying patient biology. Among 259 embryos analysed by next-generation sequencing, 56% were euploid, 27% aneuploid, and 11% mosaic, comparable to age-matched women with normal ovarian reserve, suggesting preserved chromosomal competence despite low AMH. Clinical outcomes significantly favoured the PGT group, with higher implantation rate (79% vs 52%; OR 3.43, 95% CI 1.96–5.99), clinical pregnancy rate (84% vs 65%; OR 2.96), and live birth per transfer (72% vs 50%; OR 2.56; all p < 0.01). Importantly, cumulative live birth per oocyte retrieval was higher with PGT (40% vs 26%; OR 1.91, p = 0.004), despite higher early attrition. Miscarriage rates were similar (12% vs 11%, p = 0.72). These findings suggest that PGT improves reproductive efficiency primarily through enhanced embryo selection rather than increased embryo yield. Limitations, reasons for caution The non-randomised, single-centre design limits causal inference and residual confounding cannot be excluded. Higher cycle cancellation rates reflect biological constraints related to low oocyte yield rather than PGT-related failure. Neonatal outcomes were not assessed. Wider implications of the findings In selected young women with low ovarian reserve, PGT may enhance cumulative-reproductive outcomes by optimising embryo selection, despite higher early attrition. These findings support a personalised rather than routine application of PGT in POSEIDON Group 3 patients and highlight the importance of counselling around efficiency per transfer versus per retrieval. Trial registration number No
Zitieren
APA
Nayak, R., Mantravadi, K., Gedela, D., M, S. K., & Yakasiri, V. (2026). L26/P-126 Reproductive ageing in the young: Impact of preimplantation genetic testing on cumulative live birth outcomes in POSEIDON Group 3 women. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.462
Vancouver
Nayak R, Mantravadi K, Gedela D, M SK, Yakasiri V. L26/P-126 Reproductive ageing in the young: Impact of preimplantation genetic testing on cumulative live birth outcomes in POSEIDON Group 3 women. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.462
BibTeX
@article{Nayak2026,
author = {Nayak, R. and Mantravadi, K.C. and Gedela, D.R. and M, S. Karthick and Yakasiri, V.S.},
title = {L26/P-126 Reproductive ageing in the young: Impact of preimplantation genetic testing on cumulative live birth outcomes in POSEIDON Group 3 women},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.462}
}
EUVIMED